INDO US BIOTECH
|
INDO US BIOTECH Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 7.22 | 5.71 | 8.40 | 4.18 | 4.30 |
| CEPS(Rs) | 4.02 | 3.09 | 3.67 | 1.89 | 1.60 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 54.35 | 42.41 | 35.47 | 27.05 | 28.56 |
| Tax Rate(%) | 1.98 | 4.60 | -23.53 | 11.49 | 25.70 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 15.21 | 13.85 | 13.75 | 9.97 | 9.64 |
| EBIT Margin(%) | 13.91 | 13.37 | 13.24 | 9.43 | 9.03 |
| Pre Tax Margin(%) | 11.96 | 10.97 | 10.29 | 7.20 | 7.92 |
| PAT Margin (%) | 11.73 | 10.46 | 12.72 | 6.37 | 5.88 |
| Cash Profit Margin (%) | 13.06 | 11.31 | 13.34 | 6.91 | 6.56 |
| Performance Ratios | |||||
| ROA(%) | 11.67 | 10.63 | 13.05 | 8.66 | 10.26 |
| ROE(%) | 15.51 | 17.34 | 26.87 | 16.74 | 22.21 |
| ROCE(%) | 14.62 | 15.86 | 18.30 | 16.65 | 20.35 |
| Asset Turnover(x) | 1.00 | 1.02 | 1.03 | 1.36 | 1.74 |
| Sales/Fixed Asset(x) | 9.57 | 12.72 | 21.43 | 19.95 | 17.40 |
| Working Capital/Sales(x) | 1.30 | 1.44 | 1.99 | 2.62 | 2.83 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.10 | 0.08 | 0.05 | 0.05 | 0.06 |
| Receivable days | 133.85 | 164.93 | 207.92 | 137.87 | 92.79 |
| Inventory Days | 148.59 | 128.48 | 95.73 | 91.16 | 86.98 |
| Payable days | 302.49 | -222.52 | - | 418.37 | 54.15 |
| Valuation Parameters | |||||
| PER(x) | 14.71 | 5.91 | 3.23 | 10.24 | 16.27 |
| PCE(x) | 26.41 | 10.93 | 3.69 | 11.34 | 21.89 |
| Price/Book(x) | 3.91 | 1.59 | 0.92 | 1.90 | 3.68 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 3.64 | 1.48 | 0.78 | 0.99 | 1.61 |
| EV/Core EBITDA(x) | 23.84 | 10.45 | 5.60 | 9.96 | 16.56 |
| EV/EBIT(x) | 26.14 | 11.11 | 5.86 | 10.55 | 17.80 |
| EV/CE(x) | 3.26 | 1.35 | 0.72 | 1.14 | 2.39 |
| M Cap / Sales | 3.45 | 1.24 | 0.49 | 0.78 | 1.44 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 23.36 | 24.86 | 0.82 | 12.03 | 19.82 |
| Core EBITDA Growth(%) | 32.33 | 28.02 | 39.92 | 15.23 | 18.23 |
| EBIT Growth(%) | 28.35 | 26.10 | 41.59 | 16.89 | 16.12 |
| PAT Growth(%) | 38.25 | 2.73 | 101.13 | 21.38 | 44.11 |
| EPS Growth(%) | 26.40 | -31.99 | 101.13 | -2.90 | 1.66 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.21 | 0.32 | 0.53 | 0.52 | 0.45 |
| Current Ratio(x) | 4.87 | 3.85 | 2.12 | 1.91 | 2.45 |
| Quick Ratio(x) | 2.68 | 1.94 | 1.46 | 1.36 | 1.21 |
| Interest Cover(x) | 7.15 | 5.57 | 4.50 | 4.24 | 8.10 |
| Total Debt/Mcap(x) | 0.05 | 0.20 | 0.58 | 0.28 | 0.12 |
Compare Financial Ratios of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹462.2 Cr | -0.5% | 8.5% | 208.5% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,803.1 Cr | -2.5% | -0% | 56.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,470.3 Cr | 10.3% | 39.6% | 64.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,534.0 Cr | 0.7% | 15.6% | 16% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹2,320.2 Cr | -1.1% | 7.5% | -37.5% | Stock Analytics | |
| TIERRA AGROTECH | ₹476.5 Cr | 6% | 12.8% | -40.3% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -0.5% |
8.5% |
208.5% |
| SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses
